• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤风险相关单核苷酸多态性的综合评估:系统评价与网状Meta分析方案

A comprehensive evaluation of single nucleotide polymorphisms associated with osteosarcoma risk: A protocol for systematic review and network meta-analysis.

作者信息

Ye Zhuo-Miao, Luo Ming-Bo, Zhang Chi, Zheng Jing-Hui, Gao Hong-Jun, Tang You-Ming

机构信息

Ruikang School of Clinical Medicine.

Graduate School, Guangxi University of Chinese Medicine.

出版信息

Medicine (Baltimore). 2020 Jun 26;99(26):e20486. doi: 10.1097/MD.0000000000020486.

DOI:10.1097/MD.0000000000020486
PMID:32590731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7328971/
Abstract

BACKGROUND

Single nucleotide polymorphisms (SNPs) have been inconsistently associated with osteosarcoma (OS) risk. This meta-analysis aimed to synthesize relevant data on SNPs associated with OS.

METHODS

Databases were searched to identify association studies of SNPs and OS published through January 2020 from the databases of PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure, the Chinese Science and Technology Periodical Database, and Wan fang databases. Network meta-analysis and Thakkinstian algorithm were used to select the most appropriate genetic model, along with false positive report probability for noteworthy associations. The methodological quality of data was assessed based on the STrengthening the REporting of Genetic Association Studies statement Stata 14.0 will be used for systematic review and meta-analysis.

RESULTS

This study will provide a high-quality evidence to find the SNP most associated with OS susceptibility and the best genetic model.

CONCLUSIONS

This study will explore which SNP is most associated with OS susceptibility.

REGISTRATION

INPLASY202040023.

摘要

背景

单核苷酸多态性(SNP)与骨肉瘤(OS)风险的关联并不一致。本荟萃分析旨在综合与骨肉瘤相关的SNP的相关数据。

方法

检索数据库,以识别截至2020年1月在PubMed、Web of Science、Embase、Cochrane图书馆、中国知网、中国科技期刊数据库和万方数据库中发表的SNP与骨肉瘤的关联研究。使用网络荟萃分析和Thakkinstian算法选择最合适的遗传模型,以及针对显著关联的假阳性报告概率。基于加强遗传关联研究报告声明评估数据的方法学质量。将使用Stata 14.0进行系统评价和荟萃分析。

结果

本研究将提供高质量证据,以找出与骨肉瘤易感性最相关的SNP和最佳遗传模型。

结论

本研究将探索哪种SNP与骨肉瘤易感性最相关。

注册信息

INPLASY202040023

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b4/7328971/f2358e3ddb7a/medi-99-e20486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b4/7328971/f2358e3ddb7a/medi-99-e20486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b4/7328971/f2358e3ddb7a/medi-99-e20486-g001.jpg

相似文献

1
A comprehensive evaluation of single nucleotide polymorphisms associated with osteosarcoma risk: A protocol for systematic review and network meta-analysis.骨肉瘤风险相关单核苷酸多态性的综合评估:系统评价与网状Meta分析方案
Medicine (Baltimore). 2020 Jun 26;99(26):e20486. doi: 10.1097/MD.0000000000020486.
2
A comprehensive assessment of single nucleotide polymorphisms associated with pancreatic cancer risk: A protocol for systematic review and network meta-analysis.与胰腺癌风险相关的单核苷酸多态性综合评估:系统评价与网络荟萃分析方案
Medicine (Baltimore). 2020 Jun 12;99(24):e20345. doi: 10.1097/MD.0000000000020345.
3
A comprehensive evaluation of single nucleotide polymorphisms associated with atrophic gastritis risk: A protocol for systematic review and network meta-analysis.与萎缩性胃炎风险相关的单核苷酸多态性综合评估:系统评价与网状Meta分析方案
Medicine (Baltimore). 2020 Jul 17;99(29):e20677. doi: 10.1097/MD.0000000000020677.
4
A comprehensive evaluation of association between homocysteine levels and single nucleotide polymorphisms with hypertension risk: A protocol of systematic review and network meta-analysis.同型半胱氨酸水平与单核苷酸多态性和高血压风险之间关联的综合评估:系统评价与网络荟萃分析方案
Medicine (Baltimore). 2020 Jun 26;99(26):e20791. doi: 10.1097/MD.0000000000020791.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Effectiveness and acceptability of exergaming in people with mild cognitive impairment: protocol for an overview of systematic reviews and network meta-analysis.轻度认知障碍患者进行运动游戏的有效性和可接受性:系统评价与网络荟萃分析概述的方案
Syst Rev. 2025 Jul 2;14(1):132. doi: 10.1186/s13643-025-02875-3.
9
A comprehensive evaluation of single nucleotide polymorphisms associated with gastric cancer risk: A protocol for systematic review and network meta-analysis.与胃癌风险相关的单核苷酸多态性综合评估:系统评价与网络荟萃分析方案
Medicine (Baltimore). 2020 Jun 19;99(25):e20448. doi: 10.1097/MD.0000000000020448.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

引用本文的文献

1
Toll-Like Receptor Polymorphisms and the Risk of Cancer: Meta-analysis Study.Toll 样受体多态性与癌症风险:荟萃分析研究。
Methods Mol Biol. 2023;2700:179-185. doi: 10.1007/978-1-0716-3366-3_10.
2
MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.微小 RNA34a 与骨肉瘤患者的化疗耐药性、转移、复发、生存和预后相关。
Medicine (Baltimore). 2022 Sep 23;101(38):e30722. doi: 10.1097/MD.0000000000030722.
3
Low expression of IGFBP4 and TAGLN accelerate the poor overall survival of osteosarcoma.

本文引用的文献

1
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.骨肉瘤肿瘤微环境中免疫细胞浸润和免疫相关基因的特征。
Aging (Albany NY). 2020 Feb 9;12(4):3486-3501. doi: 10.18632/aging.102824.
2
A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis.系统评价和网络荟萃分析:评估亚洲人群中与肝细胞癌风险相关的单核苷酸多态性。
Gene. 2020 Apr 20;735:144365. doi: 10.1016/j.gene.2020.144365. Epub 2020 Jan 11.
3
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
IGFBP4 和 TAGLN 低表达加速骨肉瘤患者整体生存预后不良。
Sci Rep. 2022 Jun 3;12(1):9298. doi: 10.1038/s41598-022-13163-8.
血细胞全基因组测序分析鉴定与骨肉瘤患者耐药性密切相关的胚系单倍型。
BMC Cancer. 2019 Apr 16;19(1):357. doi: 10.1186/s12885-019-5474-y.
4
Association of GSTM1, GSTT1, GSTM3, and GSTP1 Genes Polymorphisms with Susceptibility to Osteosarcoma: a Case- Control Study and Meta-Analysis.谷胱甘肽S-转移酶M1、T1、M3和P1基因多态性与骨肉瘤易感性的关联:一项病例对照研究与Meta分析
Asian Pac J Cancer Prev. 2019 Mar 26;20(3):675-682. doi: 10.31557/APJCP.2019.20.3.675.
5
Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.骨肉瘤中单核苷酸多态性:致病作用和预后意义。
Exp Mol Pathol. 2019 Feb;106:63-77. doi: 10.1016/j.yexmp.2018.12.002. Epub 2018 Dec 7.
6
Novel molecular and metabolic aspects in osteosarcoma.骨肉瘤的新型分子与代谢方面
J BUON. 2017 Nov-Dec;22(6):1595-1598.
7
Transcription Factor 21 (TCF21) rs12190287 Polymorphism is Associated with Osteosarcoma Risk and Outcomes in East Chinese Population.转录因子21(TCF21)rs12190287多态性与中国东部人群骨肉瘤风险及预后相关。
Med Sci Monit. 2017 Jun 30;23:3185-3191. doi: 10.12659/msm.905595.
8
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.成骨肉瘤的胚系和体细胞遗传学:连接病因学、生物学和治疗学。
Nat Rev Endocrinol. 2017 Aug;13(8):480-491. doi: 10.1038/nrendo.2017.16. Epub 2017 Mar 24.
9
Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.细胞毒性 T 淋巴细胞相关抗原 4 rs231775 多态性与骨肉瘤。
Neoplasma. 2017;64(2):299-304. doi: 10.4149/neo_2017_218.
10
Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.血管内皮生长因子多态性与骨肉瘤易感性相关。
Oncotarget. 2016 Jul 26;7(30):47711-47719. doi: 10.18632/oncotarget.10278.